SEATTLE, June 13, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (TPIV.OB), a biotechnology company specializing in the development of innovative therapeutics and vaccines in the areas of oncology and infectious disease, announces that Dr. Glynn Wilson, Chairman & CEO, will present at the NYC Medtech Program, a medical technology and life science forum founded by John Lieberman CPA, Managing Director of Perelson Weiner LLP, on Thursday June 14, 2012 at the offices of Kaye Scholer LLP in New York City. More information can be found at www.nycmedtech.com.
